We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Cosmo Pharmaceuticals NV (COPN) EUR0.26

Sell:64.20 CHF Buy:64.40 CHF Change: 1.00 CHF (1.58%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:64.20 CHF
Buy:64.40 CHF
Change: 1.00 CHF (1.58%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:64.20 CHF
Buy:64.40 CHF
Change: 1.00 CHF (1.58%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Cosmo Pharmaceuticals N.V. is a pharmaceutical company. The Company is focused on gastrointestinal (GI) diseases and dermatology. Its development pipeline is focused on Breezula (clascoterone), GI Genius, Methylene blue MMX, Aemcolo, CB-03-10, CB-01-33 (colesevelam), and CB-01-35. The Company's developed products include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travelers’ diarrhea (TD), Methylene Blue MMX, which is a new diagnostic drug to improve precancerous and cancerous lesion detection during colonoscopy and Winlevi for the treatment of acne. Its therapeutic focus is on the oral and endoscopic treatment of colon diseases.

Contact details

Address:
Riverside II, Sir John Rogerson's Quay
DUBLIN

Ireland
Telephone:
+353 (1) 8170370
Website:
https://www.cosmopharma.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
COPN
ISIN:
NL0011832936
Market cap:
1.11 billion CHF
Shares in issue:
16.05 million
Sector:
Pharmaceuticals
Exchange:
SIX Swiss Exchange
Country:
Netherlands
Currency:
Swiss Franc
Indices:
Swiss All Share Index

Key personnel

  • Alessandro Della Cha
    Chief Executive Officer, Executive Director, Member of the Management Board
  • Niall Donnelly
    Chief Financial Officer, Member of the Management Board
  • Marco Lecchi
    Chief Operating Officer, Member of the Management Board
  • Biagio Vigano
    Chief People Officer, Member of the Management Board
  • Andrea Cherubini
    Senior Vice President - Science, AI, and Data at Cosmo Intelligent Medical Devices, Member of the Management Board
  • Giulio Evangelisti
    Senior Vice President - Manufacturing, Service and Security at Cosmo Intelligent Medical Devices, Member of the Management Board
  • Mara Gerloni
    Senior Vice President - Preclinical Operations, Member of the Management Board
  • Luigi Longo
    Chief Scientific Officer, Member of the Management Board
  • Hazel Winchester
    Head of Investor Relations
  • Diana Harbort
    President - Dermatology Division, Member of the Management Board

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.